Biotech/Biomedical
News Category

Greenland Mines Sets Q4 Biotech Spin-Off, Focuses on Critical Minerals
Greenland Mines announced a Q4 2026 biotech spin-off, Nasdaq compliance, and a new acquisition with a high NPV, positioning it as a key rare earths pr...

Nano-X Imaging Expands Nanox.ARC Distribution in New England Through Partnership with Associated X-Ray Imaging Corp.
Nano-X Imaging's new distribution agreement with Associated X-Ray Imaging Corp. expands the reach of its Nanox.ARC system in New England, potentially ...

SS Innovations Scales SSi Mantra Surgical Robotics from India to Global Markets
SS Innovations International is expanding its SSi Mantra surgical robotic system internationally, with strong revenue growth and an increasing install...

VERAXA Biotech Appoints Raju Willener as CFO to Bolster Capital Strategy
VERAXA Biotech's appointment of Raju Willener as CFO brings extensive financial leadership to support its capital strategy and oncology pipeline devel...

Scinai Immunotherapeutics Refocuses R&D on NanoAb Platform and CDMO Growth After PinCell Termination
Scinai Immunotherapeutics strategically pivots its R&D to its NanoAb platform and CDMO business after terminating its PC111 license with PinCell, aimi...

Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing, IND, and Capital Milestones
Onco-Innovations Ltd. strengthens its clinical foundation for its lead candidate ONC010, a nanoparticle-encapsulated PNKP inhibitor, through manufactu...

Wearable Devices to Showcase Neural Sensing for Physical AI and Humanoid Robotics
Wearable Devices' participation at Physical AI 2026 highlights its neural sensing technology's role in advancing humanoid robotics and Physical AI app...

OS Animal Health Showcases Cancer Immunotherapy at Moody Capital Conference
OS Animal Health, a subsidiary of OS Therapies, presented its lead candidate OST-HER2 for canine osteosarcoma at the Disruptive Growth & Life Sciences...

Quantum BioPharma's Lucid-MS Gets FDA Clearance for Phase 2 Trial, Offering Hope for Myelin Repair in Multiple Sclerosis
Quantum BioPharma's FDA clearance to test Lucid-MS in a Phase 2 trial marks a pivotal step toward the first therapy that may repair myelin in MS patie...

Laser Therapy Shows Promise in Treating Brain Cancer
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a less invasive brain cancer treatm...

Ocumetics Begins Patient Recruitment for Group Two Clinical Study of Its Accommodating Intraocular Lens
Ocumetics Technology Corp. has initiated patient recruitment for the second group of its human clinical study, evaluating the safety and vision perfor...

Quantum BioPharma's Lucid-MS Receives FDA Clearance for Phase 2 Trial in Multiple Sclerosis
Quantum BioPharma's FDA clearance to test Lucid-MS, a first-in-class remyelinating agent, in a Phase 2 trial for MS marks a potential breakthrough in ...

NanoViricides Registers Phase II Ebola Trial for NV-387 Oral Gummies in the DRC
NanoViricides has registered its Phase II trial for NV-387 Oral Gummies against Ebola in the DRC, marking a critical step in developing an oral antivi...

Nutriband Secures Trademark Protection Milestone for Abuse-Deterrent Fentanyl Patch
Nutriband's receipt of a USPTO Notice of Publication for its AVERSA-based fentanyl patch trademarks advances its commercialization prospects, undersco...

Greenland Mines Sets Q4 Biotech Spin-Off as It Sharpens Critical Minerals Focus
Greenland Mines (NASDAQ: GRML) announced its Q4 2026 biotech spin-off and completed acquisition of the Sarfartoq project, positioning itself as a focu...

Quantum BioPharma's Lucid-MS Phase 2 Trial Clearance Signals Potential Shift in Multiple Sclerosis Treatment
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class remyelination agent, marks a pivotal step toward a new approach fo...

Quantum BioPharma Gains Spotlight as FDA Clears Lucid-MS Phase 2 Trial for Multiple Sclerosis
Quantum BioPharma's FDA clearance for its Phase 2 trial of Lucid-MS marks a significant step toward a targeted treatment for multiple sclerosis, poten...

American Fusion Expands Patent Portfolio to 130 Applications and Advances Uplisting Plans
American Fusion's expansion of its U.S. patent portfolio to 130 applications and its evaluation of a potential uplisting to a national exchange signal...

Why the 2026 Moody Capital Conference Matters for Investors in Life Sciences and AI Infrastructure
The Moody Capital 2026 Disruptive Growth & Life Sciences Conference is strategically timed to address the surge in small-cap activity in life sciences...

The LGL Group Featured in Moody Capital's Disruptive Growth & Life Sciences Conference Coverage
The LGL Group's participation in the Moody Capital conference highlights its strategic focus on precision time and frequency technologies and discipli...

Interlink Electronics to Present at Moody Capital's Disruptive Growth & Life Sciences Conference, Highlighting Expansion Across Key Markets
Interlink Electronics' participation in the Moody Capital conference underscores its strategic growth initiatives and its leadership in sensors and pr...

Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer Amid TONMYA Launch
Tonix Pharmaceuticals' promotion of Thomas Englese to Chief Commercial Officer underscores the company's strategic focus on expanding commercial opera...

Synbio International Signs Exclusive Licensing Agreement for Proprietary Nutraceutical Products, Accelerating Path to Revenue
Synbio International's exclusive licensing deal with MD PHD Wellness secures proprietary nutraceutical products, enabling near-term revenue generation...

AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership With Macro HRD SG Pte. Ltd.
AcroMeta Group has announced a strategic partnership to enter the ambient temperature cellular logistics market, with an option for an exclusive licen...

AOM Capital Provides $3.8 Million Bridge Financing to Healthcare Company
AOM Capital's $3.8 million bridge loan to a healthcare provider underscores the growing niche of receivables-backed financing to bridge reimbursement ...

Nanox Expands U.S. Distribution of Nanox.ARC Through New England Partnership
Nanox Imaging has signed a distribution agreement with Associated X-Ray Imaging Corp. to expand the reach of its FDA-cleared Nanox.ARC system in New E...

Silver and Gold ETFs Face Heavy Selling as Markets React to Warsh’s Jackson Hole Speech
Precious metals prices retreated sharply as investors recalibrated expectations for U.S. monetary policy following Warsh's remarks, impacting gold and...

Timing of Brain Metastasis Predicts Survival in Colorectal Cancer Patients
A large study reveals that the timing of brain metastasis development significantly impacts survival in colorectal cancer patients, underscoring the n...

Trump-Linked Crypto Ventures Cost Investors Billions, Report Finds
A new report reveals that investors have lost at least $4.7 billion in cryptocurrency projects tied to President Trump, highlighting the high risks of...

SS Innovations Scales Surgical Robotics Globally as Revenue Surges 39.4%
SS Innovations International's strong quarterly growth and expanding international footprint signal a pivotal shift in surgical robotics, with potenti...

VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
VERAXA Biotech's appointment of seasoned financial executive Raju Willener as CFO signals a strategic move to bolster its capital markets expertise an...

Onco-Innovations Advances ONC010 Toward Clinical Trials with High-Purity Manufacturing and Australian Regulatory Pathway
Onco-Innovations' ONC010, a PNKP inhibitor for cancer, has achieved high-purity API production and is progressing toward a First-in-Human study in Aus...

AgeReverse Showcases RESURGE at ECRM Session as U.S. Expansion Accelerates
AgeReverse's participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session marks a strategic step in its U.S. retail expansion, high...

ZC Institute Unveils Kardashev One Fusion Prototype, Initiates Independent Neutron-Deflection Tests
ZC Institute announces plans for a fusion reactor prototype that aims to recover lost energy by deflecting neutrons, with independent testing at UAH t...

Inventor Adrian Pelkus Chronicles Career and Advocates for Patent Reform in New Memoir
Adrian Pelkus's memoir highlights his inventive career and critiques U.S. patent laws that he believes undermine independent inventors.

BioVersys to Present at H.C. Wainwright 28th Annual Global Investment Conference
BioVersys AG will present a corporate overview at the H.C. Wainwright 28th Annual Global Investment Conference, highlighting its progress in developin...

OS Therapies Heads to Moody Capital Conference Amid Critical Regulatory Milestones for OST-HER2
OS Therapies' participation in the Moody Capital conference underscores a pivotal period as it awaits key regulatory decisions and survival data for i...

Immunotherapy Before Surgery Shows Promise in Glioblastoma Treatment
A Swiss preclinical study suggests that administering immunotherapy prior to surgical removal of glioblastoma tumors significantly improves treatment ...

Frontieras Leadership Experience Positioned to Drive Coal-to-Products Commercialization
Frontieras North America leverages its management team's deep industrial expertise to navigate the challenging path from technology development to com...

Nightfood Holdings Expands AI-Powered Robotics Platform Across Multiple Industries
Nightfood Holdings, operating as TechForce Robotics, is scaling its AI-driven enterprise automation platform into new sectors with strategic partnersh...

Greenland Mines Advances Sarfartoq Rare Earths and Skaergaard Palladium Projects
Greenland Mines highlights significant progress on its Sarfartoq rare earths acquisition and Skaergaard palladium project, positioning itself as a key...

Clym Environmental Opens New Ozone-Based Waste Processing Facility in Frostburg, Maryland
Clym Environmental's new facility in Frostburg, Maryland, uses ozone and solar power to process biohazardous waste, promising economic growth and sust...

FDA's Inaction Allows Black Market for Unapproved Weight-Loss Drug to Flourish Online
The FDA's failure to enforce laws against online sellers of the unapproved investigational drug retatrutide has enabled a dangerous black market that ...

Viromed Medical Appoints Prof. Dr. Michael A. Rubhausen to Medical Advisory Board
Viromed Medical AG strengthens its Medical Advisory Board with physicist Prof. Dr. Michael A. Rubhausen to enhance research in cold plasma technology ...

Regentis Biomaterials' GelrinC Advances Toward New Era of Regenerative Orthopedic Care
Regentis Biomaterials' GelrinC, a cell-free hydrogel implant for cartilage repair, shows promising clinical results and progresses toward FDA approval...

SuzieQ Holdings to Showcase Post-Quantum Security at Disruptive Growth & Life Sciences Conference
SuzieQ Holdings Inc. will be featured at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, highlighting its role in build...

